WINTER 2012

In (mobile) data we trust

Henrik Nakskov from NNIT discusses the importance of data integrity when you make clinical trials data mobile.
More..

Collecting quality patient-reported outcome data for efficacy and effectiveness

Accurate patient-reported data collection during clinical trials can be a tough outcome to achieve. Valdo Arnera MD, general manager of PHT Europe, suggests how electronic clinical outcome assessment data systems could solve this problem for the future
More..

At the heart of medicinal safety since 1978

The Uppsala Monitoring Centre produces the family of WHO Drug Dictionaries, which are used by more than 1,000 pharmaceutical companies, CROs and regulatory bodies every day.
More..

Statistically sound

With the area of biostatistics representing a crucial part of the clinical trials sector, pharmaceutical companies are on the lookout to partner with innovative outfits able to slake their requests. Supported by a small team of experts, Valos is one such player, providing a range of statistical analysis and reporting services, as managing director Dr Dmitri Petratchenko explains.
More..

SUMMER 2012

The quality dark horse in clinical data repositories

Kit Howard, owner and principal at Kestrel Consultants, explains how data standardisation is key to ensuring its quality; however, it's important that users fully understand all aspects of those standards.
More..

CDISC implementation is key to optimised clinical trials

Henrik Nakskov from NNIT discusses the need for data standardisation in the wake of big data and increasing regulations.
More..